Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tenaya Therapeutics Inc

0.4548
-0.0034-0.74%
Post-market: 0.45490.0001+0.02%19:55 EDT
Volume:1.12M
Turnover:508.64K
Market Cap:73.47M
PE:-0.35
High:0.4671
Open:0.4564
Low:0.4419
Close:0.4582
Loading ...
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 31, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]